Patents by Inventor Anita Tandle

Anita Tandle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FILIP1L compositions and methods for treating cancer
    Publication number: 20160176935
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • FILIP1L nucleic acid fragments
    Patent number: 9279009
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO:1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: March 8, 2016
    Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • FILIP1L COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20140039041
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: July 26, 2013
    Publication date: February 6, 2014
    Applicant: The United States of America, as Represented by the Secretary, Department of Health & Human Servic
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • Filipil compositions and methods for treating cancer
    Patent number: 8501912
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: August 6, 2013
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Steven K. Libutti, Mjung Kwon, Anita Tandle
  • DOC1 COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20110053850
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: December 8, 2008
    Publication date: March 3, 2011
    Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HS
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle